Monte Rosa Therapeutics (GLUE) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free GLUE Stock Alerts $5.20 -0.02 (-0.38%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Monte Rosa Therapeutics Short Interest DataCurrent Short Volume1,910,000 sharesPrevious Short Volume1,870,000 sharesChange Vs. Previous Month+2.14%Dollar Volume Sold Short$10.16 millionShort Interest Ratio / Days to Cover13.7Last Record DateApril 30, 2024Outstanding Shares50,510,000 sharesFloat Size31,760,000 sharesShort Percent of Float6.01%Today's Trading Volume153,345 sharesAverage Trading Volume187,078 sharesToday's Volume Vs. Average82% Short Selling Monte Rosa Therapeutics ? Sign up to receive the latest short interest report for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGLUE Short Interest Over TimeGLUE Days to Cover Over TimeGLUE Percentage of Float Shorted Over Time Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… Monte Rosa Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,910,000 shares $10.16 million +2.1%6.0%13.7 $5.32 4/15/20241,870,000 shares $12.29 million +11.3%5.9%14.2 $6.57 3/31/20241,680,000 shares $11.84 million -8.2%5.3%11.2 $7.05 3/15/20241,830,000 shares $11.73 million -0.5%5.8%11.2 $6.41 2/29/20241,840,000 shares $11.65 million -7.1%5.8%9.6 $6.33 2/15/20241,980,000 shares $10.95 million +3.7%6.3%9.6 $5.53 Get the Latest News and Ratings for GLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,910,000 shares $10.12 million -2.6%6.1%9.1 $5.30 1/15/20241,960,000 shares $11.76 million -4.9%6.2%8 $6.00 12/31/20232,060,000 shares $11.64 million -12.7%6.5%6.6 $5.65 12/15/20232,360,000 shares $11.80 million -20.5%7.5%7.7 $5.00 11/30/20232,970,000 shares $9.21 million -2.9%9.4%10.7 $3.10 11/15/20233,060,000 shares $11.26 million -8.7%9.7%12.1 $3.68 10/31/20233,350,000 shares $11.39 million -10.2%10.8%12.4 $3.40 10/15/20233,730,000 shares $18.02 million -6.8%12.1%15.6 $4.83 9/30/20234,000,000 shares $19.16 million +4.4%12.9%25.8 $4.79 9/15/20233,830,000 shares $23.02 million +7.9%12.4%25.8 $6.01 8/31/20233,550,000 shares $20.84 million +14.2%11.5%23.3 $5.87 8/15/20233,110,000 shares $20.46 million +11.1%10.0%19 $6.58 7/31/20232,800,000 shares $19.80 million +6.5%7.0%19.3 $7.07 7/15/20232,630,000 shares $18.33 million +1.9%6.6%14.1 $6.97 6/30/20232,580,000 shares $17.67 million +5.7%6.5%12.3 $6.85 6/15/20232,440,000 shares $18.03 million +6.6%6.1%11.9 $7.39 5/31/20232,290,000 shares $16.90 million No Change5.8%12 $7.38 5/15/20232,290,000 shares $13.40 million +2.2%5.8%13.5 $5.85 4/30/20232,240,000 shares $10.17 million -10.0%5.6%13.5 $4.54 4/15/20232,490,000 shares $17.06 million +2.9%6.3%16.5 $6.85 3/31/20232,420,000 shares $18.85 million +9.0%6.1%17.2 $7.79 3/15/20232,220,000 shares $14.50 million -3.1%5.6%15.9 $6.53 2/28/20232,290,000 shares $13.92 million -8.0%5.9%15.8 $6.08 2/15/20232,490,000 shares $16.98 million -33.2%6.4%17.1 $6.82 1/31/20233,730,000 shares $27.60 million -0.8%9.6%22.6 $7.40 1/15/20233,760,000 shares $29.37 million -13.4%9.7%25.9 $7.81 12/30/20224,340,000 shares $33.03 million +1.4%11.2%27.7 $7.61 12/15/20224,280,000 shares $40.57 million -1.8%11.1%24 $9.48 11/30/20224,360,000 shares $36.97 million -6.6%14.6%20.1 $8.48 11/15/20224,670,000 shares $43.99 million -4.3%15.7%20.7 $9.42 10/31/20224,880,000 shares $44.90 million +1.2%16.4%21.3 $9.20 10/15/20224,820,000 shares $37.45 million -6.2%16.2%21.3 $7.77 9/30/20225,140,000 shares $41.99 million +4.5%17.3%23 $8.17 9/15/20224,920,000 shares $39.26 million -3.3%16.6%24.2 $7.98get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. GLUE Short Interest - Frequently Asked Questions What is Monte Rosa Therapeutics' current short interest? Short interest is the volume of Monte Rosa Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,910,000 shares of GLUE short. 6.01% of Monte Rosa Therapeutics' shares are currently sold short. Learn More on Monte Rosa Therapeutics' current short interest. What is a good short interest ratio for Monte Rosa Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLUE shares currently have a short interest ratio of 14.0. Learn More on Monte Rosa Therapeutics's short interest ratio. What is a good short interest percentage for Monte Rosa Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.01% of Monte Rosa Therapeutics' floating shares are currently sold short. Is Monte Rosa Therapeutics' short interest increasing or decreasing? Monte Rosa Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,910,000 shares, an increase of 2.1% from the previous total of 1,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Monte Rosa Therapeutics' float size? Monte Rosa Therapeutics currently has issued a total of 50,510,000 shares. Some of Monte Rosa Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Monte Rosa Therapeutics currently has a public float of 31,760,000 shares. How does Monte Rosa Therapeutics' short interest compare to its competitors? 6.01% of Monte Rosa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Monte Rosa Therapeutics: Sutro Biopharma, Inc. (2.38%), Coherus BioSciences, Inc. (18.91%), Poseida Therapeutics, Inc. (9.73%), Agenus Inc. (16.80%), Zura Bio Limited (3.07%), Compass Therapeutics, Inc. (1.90%), Acumen Pharmaceuticals, Inc. (2.09%), Adaptimmune Therapeutics plc (1.43%), Invivyd, Inc. (9.65%), Innate Pharma S.A. (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Monte Rosa Therapeutics stock? Short selling GLUE is an investing strategy that aims to generate trading profit from Monte Rosa Therapeutics as its price is falling. GLUE shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Monte Rosa Therapeutics? A short squeeze for Monte Rosa Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLUE, which in turn drives the price of the stock up even further. How often is Monte Rosa Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLUE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STRO Short Squeeze CHRS Short Squeeze PSTX Short Squeeze AGEN Short Squeeze ZURA Short Squeeze CMPX Short Squeeze ABOS Short Squeeze ADAP Short Squeeze IVVD Short Squeeze IPHA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLUE) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWhat’s Really Next for America…Porter & CompanyWhy isn't anyone talking about this 94% options win rate?Eagle PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap Profits